Single-center Prospective Study of Non-invasive Methods for the Diagnosis of Postoperative Complications in Liver Transplant Recipients
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
100 participants
Jul 6, 2020
OBSERVATIONAL
Conditions
Summary
A lot of different early and late complications may occur after liver transplantation. They could be related to surgical procedure, to infectious diseases or immuno-mediated diseases (acute cellular rejection, ACR). Almost all of those complications are characterized by an elevation in liver enzymes (ALT, AST and GGT) and a decline of liver function tests (serum bilirubin and INR increase) possibly leading to early allograft disfunction (EAD). In this scenario there is a lack of biomarker that could predict the development of ACR and/or EAD. The aim of this study is to explore the prognostic role of non-invasive instrumental and biological marker in the early post-transplant phase.
Eligibility
Inclusion Criteria1
- Patients eligible for liver transplantation following National and International Guidelines
Exclusion Criteria3
- No agreement or inability to give informed consent
- Re-transplant patients
- Liver transplant in fulminant hepatitis
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05793203